Velosulin Unia Europejska - maltański - EMA (European Medicines Agency)

velosulin

novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Truvelog Mix 30 Unia Europejska - maltański - EMA (European Medicines Agency)

truvelog mix 30

sanofi winthrop industrie - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - truvelog mix 30 is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 10 years and above.

NovoMix Unia Europejska - maltański - EMA (European Medicines Agency)

novomix

novo nordisk a/s - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Levemir Unia Europejska - maltański - EMA (European Medicines Agency)

levemir

novo nordisk a/s - insulin detemir - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus f'adulti, adolexxenti u tfal ta 'sena u aktar.

NovoRapid Unia Europejska - maltański - EMA (European Medicines Agency)

novorapid

novo nordisk a/s - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - novorapid huwa indikat għat-trattament tad-dijabete mellitus f'adulti, adoloxxenti u tfal ta 'sena u aktar.

Ryzodeg Unia Europejska - maltański - EMA (European Medicines Agency)

ryzodeg

novo nordisk a/s - insulina aspart, l-insulina degludec - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus f'adulti, adolexxenti u tfal mill-età ta 'sentejn.

Kirsty (previously Kixelle) Unia Europejska - maltański - EMA (European Medicines Agency)

kirsty (previously kixelle)

biosimilar collaborations ireland limited - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - kirsty is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Suliqua Unia Europejska - maltański - EMA (European Medicines Agency)

suliqua

sanofi winthrop industrie - l-insulina glargine, lixisenatide - diabetes mellitus, tip 2 - drogi użati fid-dijabete - suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without sglt-2 inhibitors.

Tresiba Unia Europejska - maltański - EMA (European Medicines Agency)

tresiba

novo nordisk a/s - insulina degludec - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus fl-adulti.

Inpremzia Unia Europejska - maltański - EMA (European Medicines Agency)

inpremzia

baxter holding b.v. - insulin human (rdna) - diabetes mellitus - drogi użati fid-dijabete - inpremzia is indicated for the treatment of diabetes mellitus.